BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12584613)

  • 1. [Percutaneous radiofrequency ablation -- clinical indications and results].
    Tacke J
    Rofo; 2003 Feb; 175(2):156-68. PubMed ID: 12584613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Radiofrequency ablation of liver tumours].
    Kormann J; Ockert D; Bunk A
    Zentralbl Chir; 2001 Aug; 126(8):576-85. PubMed ID: 11518995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local ablative therapies in HCC: percutaneous ethanol injection and radiofrequency ablation.
    Mahnken AH; Bruners P; Günther RW
    Dig Dis; 2009; 27(2):148-56. PubMed ID: 19546553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation.
    Hori T; Nagata K; Hasuike S; Onaga M; Motoda M; Moriuchi A; Iwakiri H; Uto H; Kato J; Ido A; Hayashi K; Tsubouchi H
    J Gastroenterol; 2003; 38(10):977-81. PubMed ID: 14614605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Randomized clinical trial of percutaneous radiofrequency ablation plus absolute ethanol injection compared with radiofrequency ablation alone for small hepatocellular carcinoma].
    Chen MS; Zhang YJ; Li JQ; Liang HH; Zhang YQ; Zheng Y
    Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):623-5. PubMed ID: 16438875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiofrequency ablation of liver cancer.
    Lencioni R; Crocetti L
    Tech Vasc Interv Radiol; 2007 Mar; 10(1):38-46. PubMed ID: 17980317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofrequency ablation for malignant liver tumor.
    Ng KK; Poon RT
    Surg Oncol; 2005 Jul; 14(1):41-52. PubMed ID: 15777889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
    Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma.
    Harrison LE; Koneru B; Baramipour P; Fisher A; Barone A; Wilson D; Dela Torre A; Cho KC; Contractor D; Korogodsky M
    J Am Coll Surg; 2003 Nov; 197(5):759-64. PubMed ID: 14585410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The current role of minimally invasive therapies in the management of liver tumors.
    Rempp H; Boss A; Helmberger T; Pereira P
    Abdom Imaging; 2011 Dec; 36(6):635-47. PubMed ID: 21562884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interventional therapy for liver metastases].
    Ricke J
    Z Gastroenterol; 2004 Nov; 42(11):1321-8. PubMed ID: 15558444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiofrequency ablation after transarterial embolization as therapy for patients with unresectable hepatocellular carcinoma.
    Liao GS; Yu CY; Shih ML; Chan DC; Liu YC; Yu JC; Chen TW; Hsieh CB
    Eur J Surg Oncol; 2008 Jan; 34(1):61-6. PubMed ID: 17434711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment?
    Carrafiello G; Laganà D; Ianniello A; Mangini M; Fontana F; Cotta E; Concollato L; Marconi A; Recaldini C; Dionigi G; Rovera F; Boni L; Cuffari S; Fugazzola C
    Int J Surg; 2008; 6 Suppl 1():S31-5. PubMed ID: 19200792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathologic outcome of neoadjuvant image-guided therapy of hepatocellular carcinoma.
    Marin HL; Furth EE; Olthoff K; Shaked A; Soulen MC
    J Gastrointestin Liver Dis; 2009 Jun; 18(2):169-76. PubMed ID: 19565046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety of radiofrequency thermal ablation in the treatment of liver malignancies.
    Casaril A; Abu Hilal M; Harb A; Campagnaro T; Mansueto G; Nicoli N
    Eur J Surg Oncol; 2008 Jun; 34(6):668-72. PubMed ID: 17681717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review.
    Jansen MC; van Hillegersberg R; Chamuleau RA; van Delden OM; Gouma DJ; van Gulik TM
    Eur J Surg Oncol; 2005 May; 31(4):331-47. PubMed ID: 15837037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventional treatments for hepatocellular carcinoma.
    Guan YS; Liu Y
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):495-500. PubMed ID: 17085331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiofrequency ablation for the management of liver tumors.
    Bachar GN; Greif F; Mor E; Tur-Kaspa R; Belenky A
    Isr Med Assoc J; 2003 Jul; 5(7):496-500. PubMed ID: 12901246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach".
    Livraghi T; Solbiati L; Meloni F; Ierace T; Goldberg SN; Gazelle GS
    Cancer; 2003 Jun; 97(12):3027-35. PubMed ID: 12784338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of therapeutic effects between radiofrequency ablation and percutaneous microwave coagulation therapy for small hepatocellular carcinomas.
    Ohmoto K; Yoshioka N; Tomiyama Y; Shibata N; Kawase T; Yoshida K; Kuboki M; Yamamoto S
    J Gastroenterol Hepatol; 2009 Feb; 24(2):223-7. PubMed ID: 18823439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.